Systems analysis of EGF receptor signaling dynamics with microwestern arrays MF Ciaccio, JP Wagner, CP Chuu, DA Lauffenburger, RB Jones Nature methods 7 (2), 148-155, 2010 | 235 | 2010 |
Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo F Li, MJ Svarovsky, AJ Karlsson, JP Wagner, K Marchillo, P Oshel, ... Eukaryotic cell 6 (6), 931-939, 2007 | 198 | 2007 |
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts AL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ... Nature communications 11 (1), 6315, 2020 | 122 | 2020 |
The tandem duplicator phenotype as a distinct genomic configuration in cancer F Menghi, K Inaki, XY Woo, PA Kumar, KR Grzeda, A Malhotra, V Yadav, ... Proceedings of the National Academy of Sciences 113 (17), E2373-E2382, 2016 | 99 | 2016 |
Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks JP Wagner, A Wolf-Yadlin, M Sevecka, JK Grenier, DE Root, ... Science signaling 6 (284), ra58-ra58, 2013 | 62 | 2013 |
Discovery and optimization of HKT288, a Cadherin-6–Targeting ADC for the treatment of ovarian and renal cancers CU Bialucha, SD Collins, X Li, P Saxena, X Zhang, C Dürr, B Lafont, ... Cancer discovery 7 (9), 1030-1045, 2017 | 50 | 2017 |
PTMScout, a Web resource for analysis of high throughput post-translational proteomics studies KM Naegle, M Gymrek, BA Joughin, JP Wagner, RE Welsch, MB Yaffe, ... Molecular & Cellular Proteomics 9 (11), 2558-2570, 2010 | 47 | 2010 |
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms Y Wang, M Mohseni, A Grauel, JE Diez, W Guan, S Liang, JE Choi, M Pu, ... Scientific reports 11 (1), 1399, 2021 | 46 | 2021 |
Systems consequences of amplicon formation in human breast cancer K Inaki, F Menghi, XY Woo, JP Wagner, PÉ Jacques, YF Lee, ... Genome research 24 (10), 1559-1571, 2014 | 37 | 2014 |
Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts HD Kim, AS Meyer, JP Wagner, SK Alford, A Wells, FB Gertler, ... Molecular & Cellular Proteomics 10 (11), 2011 | 32 | 2011 |
A phase 1 study of a CDH6-targeting antibody-drug conjugate in patients with advanced solid tumors with evaluation of inflammatory and neurological adverse events P Schöffski, N Concin, C Suarez, V Subbiah, Y Ando, S Ruan, JP Wagner, ... Oncology research and treatment 44 (10), 547-556, 2021 | 14 | 2021 |
A CRISPR screen reveals resistance mechanisms to CD3-bispecific antibody therapy SQ Liu, A Grantham, C Landry, B Granda, R Chopra, S Chakravarthy, ... Cancer immunology research 9 (1), 34-49, 2021 | 9 | 2021 |
PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer E Lee, S Szvetecz, R Polli, A Grauel, J Chen, J Judge, S Jaiswal, ... Scientific Reports 11 (1), 14841, 2021 | 4 | 2021 |
Bayesian network inference of phosphoproteomic signaling networks J Wagner, D Lauffenburger Seventh Annual Workshop on Bayes Applications, Montreal, Canada, 2009 | 3 | 2009 |
Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance JL Cotton, J Estrada Diez, V Sagar, J Chen, M Piquet, J Alford, Y Song, ... Cancer Research 83 (21), 3611-3623, 2023 | 1 | 2023 |
Inferring copy number variation from gene expression data: methods, comparisons, and applications to oncology J Boen, JP Wagner, N Di Nanni bioRxiv, 2021.10. 18.463991, 2021 | 1 | 2021 |
Abstract PO-100: Expressed molecular barcoding coupled with single cell RNAseq enables a high resolution investigation into the evolution of drug tolerance JL Cotton, VK Radhakrishna, JE Diez, DA Ruddy, K Sprouffske, G Boulay, ... Cancer Research 80 (21_Supplement), PO-100-PO-100, 2020 | | 2020 |
Expressed molecular barcoding coupled with single cell RNAseq enables a high resolution investigation into the evolution of drug tolerance. JL Cotton, VK Radhakrishna, JE Diez, DA Ruddy, K Sprouffske, G Boulay, ... CANCER RESEARCH 80 (21), 2020 | | 2020 |
Abstract A122: Molecular barcoding and single cell approaches to investigate drug tolerance in EGFRmut NSCLC JL Cotton, V KrishnamurthyRadhakrishna, J Chen, M Piquet, J Wagner, ... Molecular Cancer Therapeutics 18 (12_Supplement), A122-A122, 2019 | | 2019 |
Abstract B137: Oncogenic chromosomal blocks in cancer genomes. JP Wagner, ET Liu Molecular Cancer Therapeutics 12 (11_Supplement), B137-B137, 2013 | | 2013 |